Advertisement

Topics

Veloxis secures $60m capital from Athyrium Capital

04:14 EST 15 Feb 2018 | Pharmaceutical Business Review

Veloxis Pharmaceuticals has secured $60m of capital from funds managed by Athyrium Capital Management, a healthcare-focused investment firm.

Original Article: Veloxis secures $60m capital from Athyrium Capital

NEXT ARTICLE

More From BioPortfolio on "Veloxis secures $60m capital from Athyrium Capital"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...